Cel-Sci Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

-0.04 (-3.70%)

As of Jun 30, 10:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +4,267.3% upside

Low Target $30.66

Average Target $45.42

High Target $56.99

Current Price $1.04

Current
$1.04

Target
$45.42

$30.66 $45.42 avg $56.99

Scenario Analysis

Bear Case

$30.66

2,848.1%

Low target

Base Case

$45.42

+4,267.3%

Avg target

Bull Case

$56.99

+5,379.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$13.48

-92.3% from high

52-Week Low

$0.89

+16.9% from low

Target vs 52W High

$45.42

+236.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%